FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD
Faculty
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Barcelona, EspañaPublications in collaboration with researchers from Institut d'Investigacions Biomèdiques August Pi i Sunyer (70)
2024
-
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial
The Lancet, Vol. 403, Núm. 10437, pp. 1649-1659
-
Optimal [18F]FDG PET/CT Cutoff for Pathologic Complete Response in HER2-Positive Early Breast Cancer Patients Treated with Neoadjuvant Trastuzumab and Pertuzumab in the PHERGain Trial
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, Vol. 65, Núm. 5, pp. 708-713
-
Prognostic value of HER2DX in early-stage HER2-positive breast cancer: a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network—Breast dataset (SCAN-B)
ESMO Open, Vol. 9, Núm. 3
-
Review of the allocation criteria for heart transplant in Spain in 2023. SEC-Heart Failure Association/ONT/SECCE consensus document
Revista Espanola de Cardiologia, Vol. 77, Núm. 1, pp. 69-78
2023
-
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer
Annals of Oncology, Vol. 34, Núm. 9, pp. 783-795
-
Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis
Diabetes Care, Vol. 46, Núm. 11, pp. 2050-2057
-
Clinical Outcomes of Critical COVID-19 in HIV-Infected Adults: A Propensity Score Matched Analysis
Archivos de Bronconeumologia, Vol. 59, Núm. 11, pp. 772-778
-
Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort
International Journal of Infectious Diseases, Vol. 137, pp. 134-143
-
Preconfigured analytical profiles for the management of patients with heart failure: a consensus-driven study
REC: CardioClinics, Vol. 58, Núm. 3, pp. 219-227
-
Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Correlative Analysis of the CALGB 40601 and PAMELA Trials
JAMA Oncology, Vol. 9, Núm. 4, pp. 490-499
-
Selection of the best of 2022 in arrhythmias and cardiac pacing
REC: CardioClinics, Vol. 58, pp. S35-S41
2022
-
Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer Patients*
British Journal of Dermatology, Vol. 187, Núm. 6, pp. 962-969
-
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer
eBioMedicine, Vol. 75
-
Early procalcitonin to predict mortality in critically ill COVID-19 patients: a multicentric cohort study
Minerva Anestesiologica, Vol. 88, Núm. 4, pp. 259-271
-
FACTOR CONVERGENCE AND PREDICTIVE ANALYSIS OF THE FIVE FACTOR AND ALTERNATIVE FIVE FACTOR PERSONALITY MODELS WITH THE FIVE-FACTOR PERSONALITY INVENTORY FOR ICD-11 (FFICD)
Journal of Personality Disorders, Vol. 36, Núm. 3, pp. 296-319
-
One-year mortality after ICU admission due to COVID-19 infection
Intensive Care Medicine
-
Selection of the best of 2021 in valvular heart diseases
REC: CardioClinics, Vol. 57, pp. S48-S53
-
Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+ breast cancer: a plain language summary of the PHERGain study
Future oncology (London, England), Vol. 18, Núm. 33, pp. 3677-3688
-
Treatable traits in the NOVELTY study
Respirology, Vol. 27, Núm. 11, pp. 929-940